SYNasdaqServices-Computer Processing & Data PreparationUS GAAP · USD

So-Young International Inc.

So-Young International Inc. operates an online-and-offline medical aesthetics platform in China that connects consumers with aesthetic treatment information, appointment booking, and treatment services. The company also runs branded aesthetic centers and develops, produces, and distributes optoelectronic medical equipment and injectable products for the beauty and medical aesthetics market.

Revenue1,523m USD
+3.9 %y/y
Operating profit (EBIT)-286m USD
+54.2 %y/y
EBIT margin-18.8%
+23.8 ppy/y
Net income-242m USD
+58.9 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-1,000-50005001,0001,5002,000m USD2020: 1,295 m USD2020: EBIT -57 m USD20202021: 1,692 m USD2021: EBIT -33 m USD20212022: 1,258 m USD2022: EBIT -103 m USD20222023: 1,498 m USD2023: EBIT -61 m USD20232024: 1,467 m USD2024: EBIT -624 m USD20242025: 1,523 m USD2025: EBIT -286 m USD20251,523-286
RevenueOperating profit (EBIT)

Business

Share of revenue
Aesthetic treatment platform services35 %

Consumer-facing online services that provide treatment information and reservations.

Aesthetic center services45 %

Offline medical aesthetics treatments delivered through branded centers.

Medical aesthetics equipment10 %

Optoelectronic devices used in aesthetic treatment settings.

Injectable products10 %

Injectable medical aesthetics products developed and distributed by the company.

Products

Reported · share of revenue
63.4%25.1%11.5%FY2024100 %
  • Information Reservation Services and Others63.4 %
  • Medical Products and Maintenance Services25.1 %
  • Aesthetic Treatment Services11.5 %

Source: 20-F FY2024, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

So-Young serves consumers seeking medical aesthetic services, including patients looking for treatments, clinic bookings, and product-based procedures. It also sells to or through its own treatment centers and channel partners in the medical aesthetics ecosystem, where product quality, affordability, and service consistency are important buying criteria.

Consumer treatment users

Individuals searching for aesthetic procedures, pricing, and appointments on the platform.

Aesthetic center patients

Consumers receiving treatments at company-operated branded centers.

Medical aesthetics product buyers

Clinics and ecosystem participants purchasing equipment and injectable products.

Strategy

So-Young’s strategy is to combine online consumer traffic with offline aesthetic centers, creating a full-service medical aesthetics ecosystem. It is also extending along the value chain into equipment and injectable products, which can support service differentiation, supply-chain control, and cross-selling across the platform and center network.

Store network expansionMedium term

More centers increase geographic reach and provide a direct offline revenue base.

Traffic-to-treatment conversionShort term

Online discovery and booking improve conversion into higher-value offline treatments.

Value-chain extensionMedium term

Equipment and injectable products deepen control over supply and support monetization.

Geography

So-Young is centered in China, where its platform, aesthetic centers, and product distribution are focused. The company also maintains investor-relations and market access links in the United States and Hong Kong through its Nasdaq listing, but its operating footprint and revenue exposure are primarily China-based.

Risks

So-Young depends on consumer demand for aesthetic treatments, which can be sensitive to discretionary spending, competition, and changes in public preferences. The business is also exposed to China-specific regulatory oversight of medical aesthetics, while its product and center operations create execution risk around quality, safety, and growth of newly opened locations.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →China consumer demand sensitivity1Regulatory and compliance risk in medical aesthetics2Reputation and quality control risk3Center ramp-up and execution risk4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. China consumer demand sensitivityImpact: HighLikelihood: High

    Aesthetic treatments are discretionary, so traffic and bookings depend on consumer confidence and spending power.

    Exposure: Platform services and center utilization

  2. Regulatory and compliance risk in medical aestheticsImpact: HighLikelihood: Medium

    Treatment delivery, devices, and injectables are subject to healthcare and product regulation in China.

    Exposure: Aesthetic centers and product distribution

  3. Reputation and quality control riskImpact: HighLikelihood: Medium

    Consumer trust is essential in aesthetics, and adverse treatment or product issues can hurt demand.

    ExposureBrandPlatformBranded centers
  4. Center ramp-up and execution riskImpact: MediumLikelihood: High

    New centers require time to reach maturity and can absorb fixed operating costs before scaling.

    Exposure: Self-operated aesthetic center network

Accounting

Judgemental items
Share-based compensation

The company excludes this from non-GAAP measures, affecting comparability to GAAP earnings.

Impact: Affects operating profit and net income presentation

Impairment of goodwill and long-lived assets

Medical aesthetics investments and centers can lose value if performance weakens.

Impact: Can create large non-cash charges in reported results

Fair value changes in long-term investments

Investment remeasurement and disposal gains/losses affect non-operating volatility.

Impact: Can move earnings even when core operations are stable

Center ramp-up accounting

New centers pass through ramp-up, growth, and maturity phases with different revenue productivity.

Impact: Creates seasonality and comparability issues across quarters

Publicly listed companies with a comparable business focus.

Last updated: 28/09/2026